Xiaoyusan
ActiveOn the Insurance distribution Radar · not rankedNot open to BackersInsurance distribution · China
Online insurance broker that designs tailored health, critical-illness and life products with Chinese insurers for groups such as young families and sells them through its platform and content.
Why Xiaoyusan is not ranked yet
How the Radar works →The Radar lists every known eligible company, sorted by date of last round, with no AI judgement. Xiaoyusan enters the ranking once its public data is sufficient for the AI to estimate it. Next Insurance distribution worldwide edition: 21 Dec 2026.
Funding history
| Date | Round | Amount | Type | Investors |
|---|---|---|---|---|
| Mar 2021 | Series C | — | Equity | Gefei Asset Management, later C+ from Tasly Holding |
Rounds as cited by Uback’s rankings. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.
Latest news
All funding or secondary sale news →Picked up from the press by Uback’s watch and summarised by Uback, with a link to the original article.
Uback rankings
How the AI ranks →| Ranking | Tier | Rank | Edition | Next update |
|---|---|---|---|---|
| Insurance distribution · worldwide | Radar | — | Edition 0 · Oct 2026 | 21 Dec 2026 |
Independent analyses
By industry professionals & analystsIndustry professionals and financial analysts can publish their own analysis of Xiaoyusan as a PDF. It must answer at least one of these four questions, and stick to them:
Analyses are the opinion of their authors, not of Uback. They are checked before publication.
Comparable companies in insurance distribution
Full insurance distribution ranking →Last updated: Oct 2026Report an error
Uback is a content publisher and an aggregator of non-binding expressions of interest. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.